EDSA Edesa Biotech Inc
Company Analysis
Latest News
🟢 Edesa Biotech is trading 6.38% up in pre-market amid broader biotech strength
Edesa Biotech is trading at $3.00, up +6.38% in pre-market, with broader biotech strength the likeliest context, though no direct cause is established. -...
🟢 Edesa Biotech is trading 14.54% up in after-hours trading with no identified company-specific explanation
Edesa Biotech is trading at $3.23, up 14.54%, with no identified company-specific announcement explaining the October 20 after-hours move. - Its latest...
🟢 Edesa Biotech is trading 5.4% up today with no new company-specific announcement identified
Edesa Biotech is trading 5.40% up at $2.93 on October 20, 2026, with no new company-specific announcement identified for the move. - The latest located...
🟢 Edesa Biotech is trading 6.5% up in after-hours trading
Edesa Biotech is trading at $2.96, up 6.47% in after-hours trading; no specific catalyst has been identified. - Edesa Biotech closed October 19 at $2.78, up...
🟢 Edesa Biotech is trading 0% up in pre-market
Edesa Biotech is trading at $2.57, 0% up in pre-market, unchanged from its October 16 close; no new company-specific announcement was identified for October...
🟢 Edesa Biotech is trading 0% up in pre-market
Edesa Biotech is trading 0% up at $2.57, unchanged from its October 16 close, with no new company-specific catalyst identified for October 19. - Supplied...
🟢 Edesa Biotech is trading 8.17% up in pre-market — no clear catalyst identified
Edesa Biotech is trading at $2.78, up 8.17%, before the October 19 open, with no clear company-specific catalyst identified. - The October 16 close was...
🟢 Edesa Biotech is trading 8.17% up in pre-market with no clear catalyst
Edesa Biotech is trading 8.17% higher at $2.78 in pre-market, with no clear catalyst identified. - The October 16 close was $2.57. - No new company...
🔴 Edesa Biotech is trading 5% down today amid broad-market sell-off and biotech weakness
Edesa Biotech is trading 5.24% lower at $2.53, in line with a sharp broader-market sell-off and weakness in biotech stocks. - Major U.S. indexes are lower,...
🟢 Edesa Biotech is trading 5% up today after FDA clears IND for EB06 vitiligo study
Edesa Biotech is trading at $2.79, up 5.09%, after FDA clearance of the IND for its Phase 2 EB06 vitiligo study. - The company announced the clearance October...
Edesa Biotech Receives FDA Clearance to Expand Phase 2 Vitiligo Study to U.S.
Edesa Biotech, Inc. announced that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application for the Phase 2...
🔴 Edesa Biotech is trading 6.5% down amid biotech and broader market weakness
Edesa Biotech is trading 6.5% down at $2.66 on October 14, 2026, alongside biotech weakness and a broader market retreat; the specific cause of the stock’s...
🟢 Edesa Biotech is trading 8% up in after-hours trading
Edesa Biotech is trading 8.04% higher in after-hours at $3.18 after closing the regular session at $2.94, with no fresh company-specific catalyst identified...
🔴 Edesa Biotech is trading 13.11% down with no clear company-specific catalyst identified
Edesa Biotech is trading 13.11% down at $3.05, with no clear company-specific catalyst identified for October 12, 2026. - The company’s news page lists its...
🔴 Edesa Biotech is trading 5% down
Edesa Biotech is trading at $3.33, down 5.13%, with no specific catalyst identified for the October 12 decline. - The company’s news page shows no October 12...
🟢 Edesa Biotech is trading 9.1% up in after-hours trading
Edesa Biotech is trading 9.1% up at $3.83 in after-hours trading on October 9; no company-specific catalyst was confirmed. - The regular-session close was...
🟢 Edesa Biotech is trading 13.39% up in after-hours trading; reason remains unclear
Edesa Biotech is trading 13.39% higher at $4.15 after-hours on October 8; no confirmed company-specific announcement explains the move. - It closed the regular...
🔴 Edesa Biotech is trading 5% down today with no confirmed company-specific catalyst
Edesa Biotech is trading 5.39% down at $3.69 amid broader risk-off pressure, with no verified company-specific catalyst identified. - The supplied market...
🔴 Edesa Biotech is trading 6% down in pre-market with no clear company-specific catalyst identified
Edesa Biotech is trading at $3.66, down 6.03%, in pre-market, with no confirmed company-specific catalyst identified for the October 8, 2026 move. - The latest...
🟢 Edesa Biotech is trading 5.8% up with no clear catalyst identified
Edesa Biotech is trading at $3.94, up 5.84%, with no clear company-specific catalyst identified. - The latest company news found predates the October 7, 2026...